Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-interventional Study of the Safety and Efficacy of Long-term Somatropin Treatment in Children (GrowthWIN II / GrowthWIN II SGA)

NCT01543867 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT01543867
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01543867 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-interventional Study of the Safety and Efficacy of Long-term Somatropin Treatment in Children (GrowthWIN II / GrowthWIN II SGA)
Lead sponsor
Novo Nordisk A/S
Phase
Observational
Overall status
Completed
Start date
January 31, 2001
Completion date
December 31, 2011
Enrollment
5,442 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

foetal growth problem, genetic disorder, growth disorder, growth hormone deficiency in children, growth hormone disorder, idiopathic short stature, small for gestational age, turner syndrome